Right dstock07734!! Does anyone know if NWBO has shared the number of patients who have gone through and/or are currently in the "specials program?" And, how about effectiveness? I thought that Dr Bosch briefly covered this topic at ASCO? I also believe that he inferred that some "compassionate use" patients were treated for "other" types of cancers v. GBM (10's??). And lastly, do patients in specials program go through current SOC first (like Phase III trial)? Same for other cancers?
Market Data 
Markets 
AI
